Agilis forms joint venture to advance gene therapy vectors – FierceBiotech
FierceBiotech |
Agilis forms joint venture to advance gene therapy vectors
FierceBiotech Agilis Biotherapeutics has formed a joint venture with Japan's Gene Therapy Research Institution (GTRI). The alliance gives Agilis a base in Japan and a partnership with a fellow CNS specialist to support its development of adeno-associated virus (AAV) … Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic Partnership |
